Table 1: EU SDHI active substance.
|
EU active substance |
Type |
MRL Annex |
Tox |
CfS |
Nb of extension/s.a (2023) |
Part (Reg. 540) |
End of approval |
AIR Program nb |
|
benzovindiflupyr/solatenol |
pyrazolecarboxamide |
II |
H331 H410 H400 H301 |
☑ |
0 |
E |
2037 |
V |
|
bixafen |
pyrazolecarboxamide |
III |
|
|
1 |
B |
2025 |
V |
|
boscalid (formerly nicobifen) |
pyridinecarboxamide |
II |
|
|
5 |
B |
2023 |
III |
|
carboxin |
Oxathiin carboxamide/cis-crotonanilide |
III |
Low ADI |
|
2 |
A |
2021 |
IV |
|
fluopyram |
pyridinylethyl benzamide |
III |
Low ADI H411 |
|
0 |
B |
2024 |
V |
|
flutolanil |
phenylbenzamide |
II |
|
|
4 |
B |
2023 |
IV |
|
fluxapyroxad |
pyrazolecarboxamide |
III |
|
|
1 |
B |
2025 |
V |
|
isofetamid |
phenyloxoethyl thiopheneamide |
II |
|
|
0 |
B |
2026 |
VI |
|
isopyrazam |
pyrazolecarboxamide |
III |
|
☑ |
0 |
B |
2022 |
V |
|
penflufen |
pyrazolecarboxamide |
II |
|
|
1 |
B |
2025 |
V |
|
penthiopyrad |
pyrazolecarboxamide |
III |
H410 H400 |
|
1 |
B |
2025 |
V |
|
sedaxane |
pyrazolecarboxamide |
III |
|
|
1 |
B |
2025 |
V |
Legend: MRL Annex= maximum residue limit number of Annex in Reg. EC 396/2005; Nb of extension/s.a = number of end of approval postponing; Part (Reg. 540) = Part from A to Ein Reg. EU540/2011; AIR program= Renewal of approval program number from 1(I) to 6(VI).